- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Velcade (Bortezomib)
Total 958 results
-
National Cancer Institute (NCI)CompletedPrimary Systemic Amyloidosis | Light Chain Deposition DiseaseUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)WithdrawnStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma
-
Seoul National University HospitalConsortium for Improving Survival of LymphomaCompletedMantle Cell LymphomaKorea, Republic of
-
University of Heidelberg Medical CenterSanofi; KKS Netzwerk; Deutsche Studiengruppe Multiples Myelom (DSMM)Recruiting
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaCanada, United States, Israel, Czechia, Turkey, Germany, United Kingdom, Japan, Netherlands, France, Brazil, Poland, Spain
-
Massachusetts General HospitalBristol-Myers Squibb; Celgene; Multiple Myeloma Research ConsortiumActive, not recruitingMultiple MyelomaUnited States
-
SanofiActive, not recruitingPlasma Cell MyelomaMexico, Sweden, Poland, France, Czechia, Greece, Taiwan, Lithuania, Portugal, Spain, Australia, Italy, New Zealand, Russian Federation, Turkey, Japan, United States, Belgium, China, Denmark, Germany
-
Merck Sharp & Dohme LLCCompleted
-
University of ArkansasWithdrawn
-
Emory UniversityTerminatedFollicular Lymphoma | Diffuse Large B-Cell Lymphoma | Myelofibrosis | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Acute Leukemia | Myelodysplastic Syndrome | Myeloproliferative Neoplasm | Small Lymphocytic Lymphoma | Graft Versus Host Disease | Chronic Myelogenous Leukemia,...United States
-
University of MiamiTerminatedLymphoma | Follicular Lymphoma | Marginal Zone LymphomaUnited States
-
Dana-Farber Cancer InstituteBristol-Myers SquibbNo longer availableMultiple Myeloma | Multiple Myeloma in RelapseUnited States
-
Janssen-Cilag G.m.b.HCompleted
-
Southwest Oncology GroupNational Cancer Institute (NCI)Completed
-
H. Lee Moffitt Cancer Center and Research InstituteMillennium Pharmaceuticals, Inc.; Ortho Biotech, Inc.CompletedMultiple MyelomaUnited States
-
IRCCS Centro di Riferimento Oncologico della BasilicataUnknown
-
Grupo de Estudos Multicentricos em Onco-HematologiaCompletedMultiple Myeloma | Effects of Chemotherapy
-
National Cancer Institute (NCI)TerminatedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple MyelomaUnited States, South Africa
-
University of ArkansasTerminatedMultiple MyelomaUnited States
-
National University of Ireland, Galway, IrelandJanssen Pharmaceuticals; Cancer Trials IrelandUnknownMultiple MyelomaIreland
-
Gruppo Italiano Malattie EMatologiche dell'AdultoCompletedRefractory Cold Agglutinin DiseaseItaly
-
University Hospital, ToulouseMinistry of Health, France; Janssen, LPCompletedMultiple MyelomaFrance, Belgium
-
Jonsson Comprehensive Cancer CenterTerminatedLymphoma | Lymphoproliferative DisorderUnited States
-
VasogenTerminatedArterial Occlusive Diseases | Peripheral Arterial Disease | Intermittent Claudication
-
VasogenCompletedHeart Failure, Congestive
-
Ruijin HospitalRecruitingGlomerulonephritis | IgA Nephropathy | FSGS | Bortezomib | MN | MPGNChina
-
University of Wisconsin, MadisonNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Oslo University HospitalHelse Stavanger HF; St. Olavs Hospital; Nordic Myeloma Study GroupActive, not recruiting
-
OncotherapeuticsCompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
National Cancer Institute (NCI)CompletedStage IIIA Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung CancerUnited States
-
Air Force Military Medical University, ChinaNot yet recruitingImmunoglobulin Light-chain Amyloidosis
-
University Hopsital Schleswig Holstein Campus LübeckRecruitingNewly Diagnosed Multiple MyelomaGermany
-
Karyopharm Therapeutics IncRecruiting
-
Dana-Farber Cancer InstituteBristol-Myers SquibbActive, not recruitingMultiple MyelomaUnited States
-
Sumitomo Pharma America, Inc.CompletedHematologic MalignancyUnited States
-
Wei ZhaoCancer Institute and Hospital, Chinese Academy of Medical SciencesUnknownHematological NeoplasmsChina
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple MyelomaUnited States
-
National Cancer Institute (NCI)NRG OncologyCompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Serous Cystadenocarcinoma | Ovarian Clear Cell Adenocarcinoma | Ovarian Mucinous... and other conditionsUnited States
-
Henrik GregersenUnknown
-
PETHEMA FoundationCelgene; Pierre Fabre Medicament; Janssen, LPCompleted
-
University of Maryland, BaltimoreMaryland Industrial Partnerships; Telcare, IncTerminated
-
National Cancer Institute (NCI)CompletedDuct Cell Adenocarcinoma of the Pancreas | Stage IV Pancreatic CancerUnited States
-
First Affiliated Hospital, Sun Yat-Sen UniversitySecond Affiliated Hospital of Guangzhou Medical UniversityUnknown
-
Johnson & Johnson Pharmaceutical Research & Development...Centocor Ortho Biotech Services, L.L.C.Withdrawn
-
Duke UniversityCephalonTerminatedMultiple MyelomaUnited States
-
CelgeneRecruitingRelapsed or Refractory Multiple MyelomaUnited States, Australia, Italy, China, Spain, Germany, Romania, Korea, Republic of, Japan, United Kingdom, Czechia, Finland, France, Greece, Argentina, Belgium, Austria, Portugal, Israel, Poland, Brazil, Turkey, Canada, Ireland, New Zealand and more
-
European Myeloma NetworkJanssen, LPActive, not recruitingMultiple Myeloma | Extramedullary PlasmacytomaTurkey, Italy, Greece
-
NYU Langone HealthMillennium Pharmaceuticals, Inc.TerminatedMultiple MyelomaUnited States
-
University Medical Center GroningenCompleted
-
University of Colorado, DenverTerminatedRefractory Plasma Cell MyelomaUnited States